KI67 EXPRESSION AFTER PREOPERATIVE CHEMOTHERAPY IN STAGE II-III BREAST CANCER IS AN INDEPENDENT PREDICTOR OF PATIENT OUTCOME

被引：0
|
作者：
Guameri, V. [1 ]
Piacentini, F. [1 ]
Ficarra, G. [2 ]
Frassoldati, A. [1 ]
Jovic, G. [1 ]
D'Amico, R. [1 ]
Giovannelli, S. [1 ]
Maiorana, A. [2 ]
Conte, P. [3 ]
机构：
[1] Modena Univ Hosp, Dept Hematol & Oncol, Modena, Italy
[2] Modena Univ Hosp, Dept Pathol, Modena, Italy
[3] Univ Modena, Univ Hosp, Dept Onc & Hem, I-41100 Modena, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [41] Can KI67 antigen expression predict the outcome of pancreatic cancer?
    Tessan, G
    Poletti, A
    Meggiato, T
    Ferrara, C
    Corsini, A
    DelFavero, G
    GASTROENTEROLOGY, 1997, 112 (04) : A487 - A487
  • [42] Neoadjuvant combination for stage II-III breast cancer
    Bagchi, Sanjit
    LANCET ONCOLOGY, 2007, 8 (07): : 579 - 579
  • [43] Neoadjuvant chemotherapy for stage II-III breast cancer: a single-center experience
    Zaher, Haidi Abd El
    Fathy, Hamada
    Abozeid, Mohamed
    Faisal, Mohammed
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [44] Changes in Ki67 expression and clinical response to neoadjuvant chemotherapy in locally advanced breast cancer (LABC)
    Devi, Desak Gede Agung Pramesti
    Purwanto, Heru
    Sandhika, Willy
    BALI MEDICAL JOURNAL, 2021, 10 (03) : 925 - 931
  • [45] Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer
    Aleskandarany, M. A.
    Green, A. R.
    Ashankyty, I.
    Elmouna, A.
    Diez-Rodriguez, M.
    Nolan, C. C.
    Ellis, I. O.
    Rakha, E. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 287 - 295
  • [46] Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer
    M. A. Aleskandarany
    A. R. Green
    I Ashankyty
    A Elmouna
    M Diez-Rodriguez
    C. C. Nolan
    I. O. Ellis
    E. A. Rakha
    Breast Cancer Research and Treatment, 2016, 158 : 287 - 295
  • [47] New Insight into Ki67 Expression at the Invasive Front in Breast Cancer
    Gong, Peng
    Wang, Yingxin
    Liu, Gavin
    Zhang, Jing
    Wang, Zhongyu
    PLOS ONE, 2013, 8 (01):
  • [48] Cosmetic outcome and pulmonary function after definitive radiation with concurrent paclitaxel chemotherapy for node-positive stage II-III breast cancer
    Kim, E
    Kim, J
    Overmoyer, B
    Silverman, P
    Cooper, B
    Anthony, S
    Shenk, R
    Lyons, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S241 - S241
  • [49] Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
    Cabrera-Galeana, Paula
    Munoz-Montano, Wendy
    Lara-Medina, Fernando
    Alvarado-Miranda, Alberto
    Perez-Sanchez, Victor
    Villarreal-Garza, Cynthia
    Marisol Quintero, R.
    Porras-Reyes, Fany
    Bargallo-Rocha, Enrique
    Del Carmen, Ignacio
    Mohar, Alejandro
    Arrieta, Oscar
    ONCOLOGIST, 2018, 23 (06): : 670 - 678
  • [50] High Ki67 expression is an independent good prognostic marker in colorectal cancer
    Melling, Nathaniel
    Kowitz, Charlotte Marie
    Simon, Ronald
    Bokemeyer, Carsten
    Terracciano, Luigi
    Sauter, Guido
    Izbicki, Jakob Robert
    Marx, Andreas Holger
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (03) : 209 - 214
12345